title: Criteria for immune trials in type I diabetes.
authors.forename: H
authors.initials: H
authors.lastname: Kolb
authors.forename: J F
authors.initials: JF
authors.lastname: Bach
authors.forename: G S
authors.initials: GS
authors.lastname: Eisenbarth
authors.forename: L C
authors.initials: LC
authors.lastname: Harrison
authors.forename: N K
authors.initials: NK
authors.lastname: Maclaren
authors.forename: P
authors.initials: P
authors.lastname: Pozzilli
authors.forename: J S
authors.initials: JS
authors.lastname: Skyler
authors.forename: C R
authors.initials: CR
authors.lastname: Stiller
mesh_terms: D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D006801:Humans
chemical_list: D003524:Cyclosporins